WHITE PAPER: a game-changing preclinical testing model for synergistic immuno-oncology drug candidates

Inovotion is a Contract Research Laboratory implementing a unique approach to in vivo evaluation for anticancer drug discovery.

As a Contract Research Organisation (CRO) that is dedicated to in vivo evaluation for drug discovery, particularly in oncology, Inovotion is a sought-after partner for drug discovery pharmaceutical and biotech companies as well as academic labs all over the world.

Inovotion’s white paper reviews the current benefits of immuno-oncology therapeutic strategies over conventional treatments and highlights the main difficulty facing drug developers today: the high combinatorial complexity of finding effective new therapies.

It also gives an in-depth view the benefits of our unique preclinical in vivo chick embryo model, with selected case studies and supporting data.

Download it  HERE!